The Study of Breast Milk IGF-1, Leptin, Ghrelin and Adiponectin Levels as Possible Reasons of High Weight Gain in Breast-Fed Infants (original) (raw)
Article navigation
Research Articles| November 14 2014
Department of Infant and Children Nutrition, Institute of Nutrition, Russian Academy of Medical Sciences, Moscow, Russian Federation
Search for other works by this author on:
Department of Infant and Children Nutrition, Institute of Nutrition, Russian Academy of Medical Sciences, Moscow, Russian Federation
Search for other works by this author on:
Department of Infant and Children Nutrition, Institute of Nutrition, Russian Academy of Medical Sciences, Moscow, Russian Federation
Search for other works by this author on:
Department of Infant and Children Nutrition, Institute of Nutrition, Russian Academy of Medical Sciences, Moscow, Russian Federation
Search for other works by this author on:
Ann Nutr Metab (2014) 65 (4): 317–323.
Abstract
Background: Excessive consumption of protein that leads to increased blood levels of insulin-like growth factor-1 (IGF-1) is an important risk factor for high growth velocity and obesity in formula-fed infants. However, it is not clear whether these factors can explain the high growth velocity in breast-fed infants. Aim: To study the possible links between the growth velocity in breast-fed infants and the levels of protein, IGF-1 and other hormones, which regulate energy homeostasis, in mothers' breast milk. Methods: We studied 103 mother-infant pairs. Their daily breast milk intake and level of IGF-1, leptin, ghrelin, adiponectin, protein and fat in breast milk were measured at 1, 2 and 3 months of lactation. The infant group was divided into three subgroups of low, normal and high weight gain tertiles. Results: The breast milk consumed by the infants with high weight gain contained higher levels of IGF-1 than that consumed by those with low weight gain at all periods studied (p = 0.032 at 3 months of lactation), and ghrelin levels were higher at 1 and 2 months and leptin levels at 2 and 3 months of lactation (p < 0.05). A positive correlation was observed between the breast milk IGF-1 level and infant weight gain (r = 0.294, p = 0.043). Total daily breast milk, fat and hormone intake was also higher in the high weight gain group compared to the low weight gain group. Conclusion: One of the reasons for the high growth velocity in breast-fed infants may be the enhanced levels of the studied hormones in breast milk.
References
Young BE, Johnson SL, Krebs NF: Biological determinants linking infant weight gain and child obesity: current knowledge and future directions. Adv Nutr 2012;3:675-686.
Heinig MJ, Nommsen LA, Peerson JM, et al: Energy and protein intakes of breast-fed and formula-fed infants during the first year of life and their association with growth velocity: the DARLING Study. Am J Clin Nutr 1993;58:152-161.
Madsen AL, Larnkjær A, Mølgaard C, Michaelsen KF: IGF-I and IGFBP-3 in healthy 9 month old infants from the SKOT cohort: breastfeeding, diet, and later obesity. Growth Horm IGF Res 2011;21:199-204.
Kon IY, Gmoshinskaya MV, Shilina NM: A comparative evaluation of the physical development of children depending on the type of feeding. Probl Paediatr Nutr 2009;7:18-20.
Weber M, Grote V, Closa-Monasterolo R, Escribano J, Langhendries JP, Dain E, Giovannini M, Verduci E, Gruszfeld D, Socha P, Koletzko B; European Childhood Obesity Trial Study Group: Lower protein content in infant formula reduces BMI and obesity risk at school age: follow-up of a randomized trial. Am J Clin Nutr 2014;99:1041-1051.
Arenz S, Rückerl R, Koletzko B, von Kries R: Breast-feeding and childhood obesity - a systematic review. Int J Obes Relat Metab Disord 2004;28:1247-1256.
Savino F, Liguori S, Fissore M, et al: Breast milk hormones and their protective effect on obesity. Int J Pediatr Endocrinol 2009;2009:327505.
Woo JG, Guerrero ML, Guo F, Martin LJ, Davidson BS, Ortega H, Ruiz-Palacios GM, Morrow AL: Human milk adiponectin affects infant weight trajectory during the second year of life. J Pediatr Gastroenterol Nutr 2012;54:532-539.
Manual on the Methods of Control and Safety of Food Supplements. Manual R 4.1.1672-2003. Moscow, Ministry of Health of the Russian Federation, 2004, pp 8-11.
Leibel RL, Behary N, Friedman JF: Strategies for the molecular genetic analysis of obesity in humans. Crit Rev Food Sci Nutr 1993;33:351-358.
Melnik BC, John SM, Schmitz G: Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth. Nutr J 2013;12:103.
Milson SR, Blum WF, Gunn AJ: Temporal changes in insulin-like growth factors I and II and in insulin-like growth factor binding proteins 1, 2, and 3, in human milk. Horm Res 2008;69:307-311.
Elmlinger MW, Hochhaus F, Loui A, Frommer KW, Oladen M, Ranke MB: Insulin-like growth factors and binding proteins in early milk from mothers of preterm and term infants. Horm Res 2007;68:124-131.
Ozgurtas T, Aydin I, Turan O, et al: Vascular endothelial growth factor, basic fibroblast growth factor, insulin-like growth factor-I and platelet-derived growth factor levels in human milk of mothers with term and preterm neonates. Cytokine 2010;50:192-194.
Pawlus B, Walczak M, Kordek A, Gizewska M, Czajka R: Impact of delivery type on EGF and IGF-1 concentration in umbilical blood of newborns and their mother's milk (in Polish). Ginekol Pol 2004;75:821-824.
Blum JW, Baumrucker CR: Colostral and milk insulin-like growth factors and related substances: mammary gland and neonatal (intestinal and systemic) targets. Domest Anim Endocrinol 2002;23:101-110.
Ballard O, Morrow AL: Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am 2013;60:49-74.
Hainerova IA, Lebl J: Mechanisms of appetite regulation. J Pediatr Gastroenterol Nutr 2010;51:S123-S124.
Bouret SG: Development of hypothalamic neural network controlling appetite. Forum Nutr 2010;63:84-93.
Barrenetxe J, Villaro AC, Guembe L, et al: Distribution of the long leptin receptor isoform in brush border, basolateral membrane, and cytoplasm of enterocytes. Gut 2002;50:797-802.
Uçar B, Kirel B, Bör O, Kiliç FS, Doğruel N, Aydoğdu SD, Tekin N: Breast milk leptin concentrations in initial and terminal milk samples: relationships to maternal and infant plasma leptin concentrations, adiposity, serum glucose, insulin, lipid and lipoprotein levels. J Pediatr Endocrinol Metab 2000;13:149-156.
Savino F, Benetti S, Lupica MM, et al: Ghrelin and obestatin in infants, lactating mothers and breast milk. Horm Res Paediatr 2012;78:297-303.
Savino F, Lupica MM, Liguori SA, et al: Ghrelin and feeding behaviour in preterm infants. Early Hum Dev 2012;88(suppl 1):S51-S55.
Newburg DS, Woo JG, Morrow AL: Characteristics and potential functions of human milk adiponectin. J Pediatr 2010;156:S41-S46.
Gavrila A, Chan JL, Yiannakouris N, et al: Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823-4831.
Hugo ER, Brandebourg TD, Woo JG, et al: Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 2008;116:1642-1647.
Savino F, Lupica M, Benetti S, et al: Adiponectin in breast milk: relation to serum adiponectin concentration in lactating mothers and their infants. Acta Paediatr 2012;101:1058-1062.
Woo JG, Guerrero ML, Altaye M, et al: Human milk adiponectin is associated with infant growth in two independent cohorts. Breastfeed Med 2009;4:101-109.
Weyermann M, Brenner H, Rothenbacher D: Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study. Epidemiology 2007;18:722-729.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
Sign in
Digital Version
Pay-Per-View Access
$39.00
1 Karger Article Bundle Token
$150
Rental
This article is also available for rental through DeepDyve. 